Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Interest & Investment Income (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Interest & Investment Income data on record, last reported at $736000.0 in Q3 2025.

  • For Q3 2025, Interest & Investment Income rose 24.96% year-over-year to $736000.0; the TTM value through Sep 2025 reached $2.4 million, down 17.02%, while the annual FY2024 figure was $2.7 million, 10.66% down from the prior year.
  • Interest & Investment Income reached $736000.0 in Q3 2025 per FBIO's latest filing, up from $622000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.0 million in Q1 2023 and bottomed at $132000.0 in Q3 2021.
  • Average Interest & Investment Income over 5 years is $504210.5, with a median of $547000.0 recorded in 2023.
  • Peak YoY movement for Interest & Investment Income: tumbled 63.8% in 2021, then surged 629.58% in 2023.
  • A 5-year view of Interest & Investment Income shows it stood at $144000.0 in 2021, then skyrocketed by 377.08% to $687000.0 in 2022, then increased by 2.62% to $705000.0 in 2023, then decreased by 25.39% to $526000.0 in 2024, then soared by 39.92% to $736000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $736000.0 in Q3 2025, $622000.0 in Q2 2025, and $490000.0 in Q1 2025.